Evaluation of the Protective Effects of Quercetin, Rutin, Naringenin, Resveratrol and Trolox Against Idarubicin-Induced DNA Damage
PURPOSE. Idarubicin is a synthetic anthracycline anticancer drug widely used in the treatment of some hematological malignancies. The studies in our laboratory have clearly demonstrated that idarubicin can undergo reductive bioactivation by NADPH-cytochrome P450 reductase to free radicals with resul...
主要な著者: | , |
---|---|
フォーマット: | 論文 |
言語: | English |
出版事項: |
Frontiers Media S.A.
2010-07-01
|
シリーズ: | Journal of Pharmacy & Pharmaceutical Sciences |
オンライン・アクセス: | https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/7167 |